No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 2.300
- 0.0000.00%
Trading Jun 25 10:36 ET
12.53MMarket Cap-74193P/E (TTM)
0.000High0.000Low227Volume2.120Open2.300Pre Close0.00Turnover0.01%Turnover RatioLossP/E (Static)5.45MShares4.99052wk High4.64P/B9.50MFloat Cap0.75052wk Low--Dividend TTM4.13MShs Float600.000Historical High--Div YieldTTM0.00%Amplitude0.625Historical Low0.000Avg Price1Lot Size
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed ref
XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy >XTLB
XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy >XTLB
XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement
XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement
XTL Entered Definitive Agreement To Acquire The Social Proxy >XTLB
XTL Entered Definitive Agreement To Acquire The Social Proxy >XTLB
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersSINTX Techs (NASDAQ:SINT) shares increased by 22.2% to $0.16 during Wednesday's after-market session. The company's market cap stands at $19.1 million. As per the news, the Q1 earnings report c
XTL Biopharmaceuticals Expands Portfolio Amidst Profitable Quarter
Comments
$XTL Biopharmaceuticals(XTLB.US$ XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement. XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy
1
$XTL Biopharmaceuticals(XTLB.US$ closing out on this one, holding $Altamira Therapeutics(CYTO.US$ all week for the squeeze. some sources im seeing say CYTO only has a 325k float since the RS last december. makes it very easy to manipulate, but can also easily 10x
14
XTL Biopharmaceuticals Leverages AI in Healthcare with The Social Proxy Acquisition.
In an unexpected yet strategic move, XTL Biopharmaceuticals Ltd (NASDAQ: XTLB) announced its acquisition of The Social Proxy, a decision that has sent ripples through both the biopharmaceutical and tech industries. This acquisition not only marks XTL's ambitious expansion into the AI and web data sphere but also signific...
In an unexpected yet strategic move, XTL Biopharmaceuticals Ltd (NASDAQ: XTLB) announced its acquisition of The Social Proxy, a decision that has sent ripples through both the biopharmaceutical and tech industries. This acquisition not only marks XTL's ambitious expansion into the AI and web data sphere but also signific...
$XTL Biopharmaceuticals(XTLB.US$ wish I got in lol def hitting 3
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg